Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease.
Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, Jény R, Bartolomeo P, Boissé MF, Barba GD, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, Rémy P, Palfi S, Defer GL, Cesaro P, Hantraye P, Peschanski M. Bachoud-Lévi A, et al. Among authors: bourdet c. Exp Neurol. 2000 Jan;161(1):194-202. doi: 10.1006/exnr.1999.7239. Exp Neurol. 2000. PMID: 10683285 Clinical Trial.
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.
Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M. Bachoud-Lévi AC, et al. Among authors: bourdet c. Lancet. 2000 Dec 9;356(9246):1975-9. doi: 10.1016/s0140-6736(00)03310-9. Lancet. 2000. PMID: 11130527 Clinical Trial.
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.
Bachoud-Lévi AC, Déglon N, Nguyen JP, Bloch J, Bourdet C, Winkel L, Rémy P, Goddard M, Lefaucheur JP, Brugières P, Baudic S, Cesaro P, Peschanski M, Aebischer P. Bachoud-Lévi AC, et al. Among authors: bourdet c. Hum Gene Ther. 2000 Aug 10;11(12):1723-9. doi: 10.1089/10430340050111377. Hum Gene Ther. 2000. PMID: 10954906
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
Bloch J, Bachoud-Lévi AC, Déglon N, Lefaucheur JP, Winkel L, Palfi S, Nguyen JP, Bourdet C, Gaura V, Remy P, Brugières P, Boisse MF, Baudic S, Cesaro P, Hantraye P, Aebischer P, Peschanski M. Bloch J, et al. Among authors: bourdet c. Hum Gene Ther. 2004 Oct;15(10):968-75. doi: 10.1089/hum.2004.15.968. Hum Gene Ther. 2004. PMID: 15585112 Clinical Trial.
Chronic high dose transdermal nicotine in Parkinson's disease: an open trial.
Villafane G, Cesaro P, Rialland A, Baloul S, Azimi S, Bourdet C, Le Houezec J, Macquin-Mavier I, Maison P. Villafane G, et al. Among authors: bourdet c. Eur J Neurol. 2007 Dec;14(12):1313-6. doi: 10.1111/j.1468-1331.2007.01949.x. Epub 2007 Oct 17. Eur J Neurol. 2007. PMID: 17941858 Clinical Trial.
Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies.
Callaghan J, Stopford C, Arran N, Boisse MF, Coleman A, Santos RD, Dumas EM, Hart EP, Justo D, Owen G, Read J, Say MJ, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Bachoud-Levi AC, Bourdet C, van Duijn E, Craufurd D. Callaghan J, et al. Among authors: bourdet c. J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):59-64. doi: 10.1176/appi.neuropsych.13070169. J Neuropsychiatry Clin Neurosci. 2015. PMID: 25716488
20 results